SUZHOU ZELGEN BIOPHARMACEUTICALS CO.,LTD financial statements, including revenue, expenses, profit, and loss

The total revenue of 688266 for the last quarter is 143.12 M CNY, and it's 8.32% higher compared to the previous quarter. The net income of Q3 24 is -31.37 M CNY.